U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852157) titled 'Evaluation of the Diagnostic and Prognostic Value of Immunohistochemical Markers in Precancerous Lesions of the Cervix' on Dec. 01, 2024.
Brief Summary: The study aims to evaluate the expression of certain proteins and their diagnostic and prognostic value in precancerous lesions of the cervix.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Cervix Cancer
Intervention:
DIAGNOSTIC_TEST: Tissue, diagnostic and prognostic accuracy
The clinical data and histological samples of patients with a diagnosis of CIN/SIL on cervical biopsies or conization (performed as required by the normal procedure) will be consecut...